INNT
TOTAL INVALIDATION PROCESSED BY THE IB
03/20/2023
Back to search
Official data from USPTO
BLISSEL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
03/20/2023
Trademark type
Combined
Nice classes
5
Filing date
02/09/2011
Registration date
11/01/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/13/2022
Last transaction
05/13/2022
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
ALCOBENDAS (Madrid), ES
Examiner
GLASSER, CARYN
Law office
L80
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
ITALFARMACO, S.A.
ITALFARMACO, S.A.
Representatives
Nancy Sabarra FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Gynecological pharmaceutical products for treatment of vulvovaginal atrophy
Publications
History of USPTO decisions and trademark events.
30 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
03/01/2023
INPC
INVALIDATION PROCESSED
03/01/2023
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
01/13/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/01/2023
C71T
CANCELLED SECTION 71
05/13/2022
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
11/01/2020
RNWL
INTERNATIONAL REGISTRATION RENEWED
09/24/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/23/2020
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
01/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/10/2019
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
03/15/2018
71AG
REGISTERED-SEC.71 ACCEPTED
03/15/2018
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
03/06/2018
PR71
POST REGISTRATION ACTION MAILED - SEC.71
10/31/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/18/2017
ES71
TEAS SECTION 71 RECEIVED
09/20/2017
GPNX
NOTIFICATION PROCESSED BY IB
06/14/2012
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/11/2012
FIMP
FINAL DISPOSITION PROCESSED
04/11/2012
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
12/01/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
11/01/2011
PUBO
PUBLISHED FOR OPPOSITION
08/16/2011
NPUB
NOTICE OF PUBLICATION
07/27/2011
MAFR
APPLICATION FILING RECEIPT MAILED
07/16/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/12/2011
DOCK
ASSIGNED TO EXAMINER
07/12/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/12/2011
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
07/11/2011
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
07/09/2011
Continuous trademark protection
Get notified about every new filing that threatens BLISSEL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.